Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
28 Apr 2022 17:53 CEST |
PHOTOCURE | Photocure ASA - Annual general meeting held | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
26 Apr 2022 15:32 CEST |
PHOTOCURE | Photocure ASA: Final grant of conditional share options | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
07 Apr 2022 13:05 CEST |
PHOTOCURE | Photocure ASA - Notice of the annual general meeting 28 April 2022 | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
06 Apr 2022 20:51 CEST |
PHOTOCURE | Photocure ASA: Annual Report 2021 | 20103015 Pharmaceuticals | Annual financial and audit Reports |
29 Mar 2022 17:00 CEST |
PHOTOCURE | Photocure to Participate in Two Investor Conferences in April: DNB Small & Medium Enterprises and Needham Healthcare | 20103015 Pharmaceuticals | Non-regulatory press releases |
16 Mar 2022 11:04 CET |
PHOTOCURE | Photocure ASA: Share capital increase registered | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
14 Mar 2022 13:01 CET |
PHOTOCURE | Photocure ASA: Exercise of employee share options and share capital increase | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
04 Mar 2022 08:00 CET |
PHOTOCURE | Photocure announces Endotherapeutics Group as New Commercial Partner for Hexvix in Australia & New Zealand | 20103015 Pharmaceuticals | Non-regulatory press releases |
28 Feb 2022 07:30 CET |
PHOTOCURE | Photocure Announces the Publication of Pre-Clinical Study Results Supporting the Anti-tumor Effect of Hexaminolevulinate with Blue Light in Bladder Cancer model | 20103015 Pharmaceuticals | Non-regulatory press releases |
23 Feb 2022 07:30 CET |
PHOTOCURE | Photocure ASA: Results for the fourth quarter of 2021 | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
17 Feb 2022 10:05 CET |
PHOTOCURE | Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2021 financial results | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
11 Feb 2022 10:05 CET |
PHOTOCURE | Photocure Partner Asieris announces Approval to conduct a Phase III Clinical Trial for Hexvix in China | 20103015 Pharmaceuticals | Non-regulatory press releases |
08 Feb 2022 15:07 CET |
PHOTOCURE | Major shareholder disclosure in Photocure ASA | 20103015 Pharmaceuticals | Major shareholding notifications |
07 Feb 2022 07:23 CET |
PHOTOCURE | Bladder Cancer technology: New improved Blue Light Cystoscopy system receives FDA approval for use in NMIBC in the U.S. | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
04 Feb 2022 08:10 CET |
PHOTOCURE | Photocure ASA – Major shareholding disclosure | 20103015 Pharmaceuticals | Major shareholding notifications |
20 Jan 2022 08:56 CET |
PHOTOCURE | Major shareholder disclosure - Photocure ASA | 20103015 Pharmaceuticals | Major shareholding notifications |
21 Dec 2021 13:15 CET |
PHOTOCURE | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
20 Dec 2021 10:04 CET |
PHOTOCURE | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
09 Dec 2021 14:17 CET |
PHOTOCURE | Photocure ASA: Share capital increase registered | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
06 Dec 2021 20:15 CET |
PHOTOCURE | Photocure ASA: Exercise of employee share options | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
03 Dec 2021 08:30 CET |
PHOTOCURE | Photocure ASA: Exercise of employee share options and share capital increase | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
02 Dec 2021 16:53 CET |
PHOTOCURE | Major shareholder disclosure in Photocure ASA | 20103015 Pharmaceuticals | Major shareholding notifications |